亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

北京普華仕科技發展有限公司  

沒有填寫主營業務~~

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:周女士
  • 電話:010-61242659
  • QQ:1747853905
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 16611-84-0Anacardic acid
16611-84-0Anacardic acid
單價 面議對比
詢價 暫無
發貨 北京付款后3天內
型號 16611-84-0
過期 長期有效
更新 2014-08-31 15:22
 
詳細信息

Anacardic acid
Cell permeable salicylic acid analog that acts as a potent, non-*petitive inhibitor of p300 and PCAF (p300/CBP-associated factor) histone acetyltransferase (HAT) activities (IC50~8.5µM and ~5µM, respectively). Displays a variety of other biological activities, such as antibacterial, antimicrobial, prostaglandin synthase inhibition, tyrosinase, and lipoxygenase inhibition.Inhibits SUMOylation of RanGAP1-C2 with an IC50 = 2.2µM
PRODUCT PROPERTIES
Alternative Name:
 
2-Hydroxy-6-pentadecylbenzoic acid, 6-Pentadecylsalicylic acid, AA
MI:
 
14: 621
Source/Host:
 
Synthetic.
Solubility:
 
Soluble in 100% ethanol, methanol, DMSO, dichloromethane or ethylacetate.
Long Term Storage:
 
+4°C
Use/Stability:
 
Stock solutions are stable for up to 3 months when stored at -20°C.
Hazard:
 
IRRITANT.
Handling:
 
After reconstitution, prepare aliquots and store at -20°C.
Packaged under inert gas.
Protect from light.
MW:
 
348.5
CAS:
 
16611-84-0
Formula:
 
C22H36O3
Purity:
 
≥95% (1H-NMR)
Appearance:
 
White to off-white solid.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
普華仕科技發展有限公司 --Puhuashi Technology Development Co., Ltd
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
索取產品詳細資料,查詢更多其它產品,
請致電:010-61242659、60211811,
寫郵件至:sales@puhs-tech.*,
或進入我司網站***.puhs-tech.*首頁“在線客服”“在線留言”系統,
我們的客服人員會盡快回復您。
客服QQ:1446645907、1747853905、2627176950、1826321165
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
©2025 北京普華仕科技發展有限公司 版權所有   技術支持:化工網   訪問量:15782  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |